Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer.
Uçar G, Sekmek S, Karahan İ, Ergün Y, İsak ÖA, Tunç S, Doğan M, Gürler F, Bayram D, Açıkgöz Y, Esen SA, Civelek B, Köş FT, Bal Ö, Algın E, Eren T, İmamoğlu Gİ, Urakçı Z, Yazıcı O, Özdemir N, Uncu D. Uçar G, et al. Among authors: uncu d. Oncology. 2024 Jul 30:1-6. doi: 10.1159/000540517. Online ahead of print. Oncology. 2024. PMID: 39079501 Free article.
The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients: A Multicenter Real-Life Study.
Akdeniz N, Kaplan MA, İnanç M, Uncu D, Ergün Y, Küçüköner M, Demirci A, Şendur MAN, Beşiroğlu M, Topçu A, Yerlikaya H, Urakçi Z, Kiliçkap S, Işikdoğan A. Akdeniz N, et al. Among authors: uncu d. Pancreas. 2022 Oct 1;51(9):1153-1159. doi: 10.1097/MPA.0000000000002167. Pancreas. 2022. PMID: 37078939
Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer.
Karacin C, Sunar V, Urakci Z, Yilmaz A, Ayhan M, Ersoy M, Guven DC, Erturk I, Durmus Y, Karacin P, Boran N, Ustun YE, Meydan M, Dogan M, Oksuzoğlu B, Ates O, Karaca M, Uncu D, Ergun Y, Arik Z. Karacin C, et al. Among authors: uncu d. Future Oncol. 2024 Feb;20(4):207-214. doi: 10.2217/fon-2023-0763. Epub 2024 Feb 8. Future Oncol. 2024. PMID: 38328890
Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia.
Sevinç A, Özkan M, Özet A, Dane F, Öksüzoğlu B, Işıkdoğan A, Özdemir F, Uncu D, Gümüş M, Evrensel T, Yaren A, Kara O, Tekin SB. Sevinç A, et al. Among authors: uncu d. Onco Targets Ther. 2018 Jan 18;11:419-426. doi: 10.2147/OTT.S106342. eCollection 2018. Onco Targets Ther. 2018. PMID: 29403286 Free PMC article.
The Relationship Between Plexin C1 Overexpression and Survival in Hepatocellular Carcinoma: a Turkish Oncology Group (TOG) Study.
NazimTurhal S, Dogan M, Esendagli G, Artac M, Korkmaz L, Coskun HS, Goker E, PerranYumuk F, Bilgetekin I, Kose F, Uncu D, Kavgaci H, Akyol G, Ozet A, Yagci T. NazimTurhal S, et al. Among authors: uncu d. J Gastrointest Cancer. 2022 Jun;53(2):356-362. doi: 10.1007/s12029-021-00602-4. Epub 2021 Mar 3. J Gastrointest Cancer. 2022. PMID: 33656690
Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy.
Karacin C, Eren T, Zeynelgil E, Imamoglu GI, Altinbas M, Karadag I, Basal FB, Bilgetekin I, Sutcuoglu O, Yazici O, Ozdemir N, Ozet A, Yildiz Y, Esen SA, Ucar G, Uncu D, Dinc B, Aykan MB, Erturk İ, Karadurmus N, Civelek B, Çelik İ, Ergun Y, Dogan M, Oksuzoglu OB. Karacin C, et al. Among authors: uncu d. Future Oncol. 2021 Nov;17(33):4447-4456. doi: 10.2217/fon-2021-0597. Epub 2021 Aug 3. Future Oncol. 2021. PMID: 34342517 Free PMC article.
Thirty-day mortality rates after immunotherapy initiation.
Sütcüoğlu O, İlhan A, Tacar SY, Güven DC, Uçar G, Karadurmuş N, Yıldız F, Eraslan E, Uncu D, Tural D, Üner A, Günel N, Özdemir N, Kılıçkap S, Öksüzoğlu ÖB, Özet A, Yazıcı O. Sütcüoğlu O, et al. Among authors: uncu d. Immunotherapy. 2021 Dec;13(17):1419-1426. doi: 10.2217/imt-2021-0082. Epub 2021 Oct 22. Immunotherapy. 2021. PMID: 34676791
113 results